ATMP Forum
  • Home
  • ATMP FORUM
    • Chi Siamo
  • Attività
    • Report ATMP Forum
    • Articoli e Documenti
    • interviste
    • I nostri eventi
  • Contatti
  • foto
    • patient atmp forum
    • Regional ATMP forum 2023
    • Regional ATMP forum 2024
    • ATMP DAYS 2023
      • ATMP: Work in Progress – 11 Ottobre 23
      • PRESENTAZIONE VI Report Italiano sugli ATMP – 12 ottobre 2023
Seleziona una pagina

UPDATE 1-NOVARTIS CAR-T THERAPY LEADS TO DURABLE RESPONSE IN LYMPHOMA STUDY

da Admin | Dic 10, 2017 | Clinical

“http://www.businessinsider.com/”

UPDATE 1-NOVARTIS CAR-T THERAPY LEADS TO DURABLE RESPONSE IN LYMPHOMA STUDY

da Admin | Dic 10, 2017 | Clinica

“http://www.businessinsider.com/”

CELGENE, BLUEBIRD REPORT PROMISING CAR-T MYELOMA STUDY

da Admin | Dic 10, 2017 | Business

“https://www.pharmamanufacturing.com”

CELGENE, BLUEBIRD REPORT PROMISING CAR-T MYELOMA STUDY

da Admin | Dic 10, 2017 | Business

“https://www.pharmamanufacturing.com”
©PHARMALEX Italy S.P.A. con socio unico - Largo Donegani, 2 - 20121 Milano - P.IVA/CF 10092550960 ITALY
Info: info@atmpforum.com - privacy policy